Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial - Tap, WD; Jones, RL; Van Tine, BA; Chmielowski, B; Elias, AD; Adkins, D; Agulnik, M; Cooney, MM; Livingston, MB; Pennock, G; Hameed, MR; Shah, GD; Qin, A; Shahir, A; Cronier, DM; Ilaria, R, Jr; Conti, I; Cosaert, J; Schwartz, GK (Lancet, 2016)
. Epub 2016 Jun 9